$OMHE NEWS Andrey Soloviev, Omni Health Chief Executive Officer, stated: “We are excited to partner with MediCann which brings long standing relationships with key distributors in Europe. With a population of more than 740 million people and a strong consumer demand for anti-aging and CBD products, European countries represent an attractive new growth opportunity,” He added: “This €3,700,000 deal is one of several now in works for further global distribution and licensing of a very strong portfolio of formulations Omni Health has developed over the past 4 decades. We are pleased that there is much here for us to build upon to develop new market and application opportunities.”
"We are extremely honored to work with Omni Health because of their decades of experience in bringing innovative healthcare products to market. We are looking forward to distribute Omni Health products throughout Europe.” said Carsten SIegemund, CEO of MediCann.
This latest development strategically positions Omni Health at the forefront of global CBD consumer goods market, and will further strengthen its P&L and financial positions
Dear $OMHE Shareholders,
As we move into the second quarter (our financial year ends April 30th), I can honestly say that I have never been more optimistic about our opportunities for success. Omni Health’s annual revenues have grown to more than $4.6mln